Predictive efficacy of low burden EGFR mutation detected by next-generation sequencing on response to EGFR TKIs in non-small-cell lung carcinoma

被引：0
|
作者：
Kim, H. [1 ]
Lee, S. Y. [1 ]
Choi, Y. J. [1 ]
Kim, J. S. [1 ]
Kim, S. T. [1 ]
Park, K. H. [1 ]
Shin, S. W. [1 ]
Kim, Y. H. [1 ]
机构：
[1] Korea Univ, Anam Hosp, Seoul, South Korea
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
704
引用
收藏
页码：S156 / S156
页数：1
相关论文
共 50 条
  • [31] Clinical Efficacy and Safety of Apatinib Combined with EGFR - TKIs in Advanced Non-Small Cell Lung Cancer with EGFR - TKIs Resistance
    Song, X.
    Tian, R.
    Guo, Y.
    Zhang, X.
    Guo, W.
    Zhu, H.
    Shen, F.
    Xu, J.
    Zhang, X.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S590 - S590
  • [32] Concurrent gene alterations with EGFR mutation and treatment efficacy of EGFR-TKIs in Chinese patients with non-small cell lung cancer
    Hu, Wentao
    Liu, Yahui
    Chen, Jian
    ONCOTARGET, 2017, 8 (15) : 25046 - 25054
  • [33] AFATINIB IN EGFR MUTANT NON-SMALL-CELL LUNG CANCER PATIENTS WITH ACQUIRED RESISTANCE TO REVERSIBLE EGFR-TKIS
    Cappuzzo, Federico
    Tiseo, Marcello
    Chiari, Rita
    Landi, Lorenza
    Ricciardi, Serena
    Rossi, Elisa
    Galetta, Domenico
    Novello, Silvia
    Milella, Michele
    D'Incecco, Armida
    Haspinger, Eva Regina
    Cortinovis, Diego
    Santo, Antonio
    Banna, Giuseppe
    Facchi-Netti, Francesco
    Levra, Matteo Giaj
    Vari, Sabrina
    Crino, Lucio
    De Marinis, Filippo
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S610 - S610
  • [34] EGFR mutation and response to chemotherapy in non-small-cell lung cancer (NSCLC) patients.
    Lee, KH
    Han, SW
    Jeong, S
    Kim, DW
    Chung, DH
    Im, SA
    Kim, TY
    Heo, DS
    Bang, YJ
    Kim, NK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 641S - 641S
  • [35] Improved detection of druggable EGFR variants in non-small cell lung cancer using targeted next-generation sequencing
    Szpechcinski, Adam
    Moes-Sosnowska, Joanna
    Lechowicz, Urszula
    Skronska, Paulina
    Pelc, Magdalena
    Szolkowska, Malgorzata
    Wojda, Emil
    Rudzinski, Piotr
    Maszkowska-Kopij, Krystyna
    Polaczek, Mateusz
    Langfort, Renata
    Sliwinski, Pawel
    Orlowski, Tadeusz
    Chorostowska-Wynimko, Joanna
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [36] Emergence of EGFR Mutations in Exon 18 and 20 in Non-Small-Cell Lung Cancer to Predict the Next-Generation Targeted Therapy
    Ahmed, Zeeshan Ansar
    Naz, Samra
    Nasir, Asghar
    Ujala, Anum
    Moatter, Tariq
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (06): : S46 - S46
  • [37] ALK, ROS1 and EGFR next-generation tyrosine kinase inhibitors in advanced non-small-cell lung cancer
    Winiarczyk, Kinga
    Piorek, Aleksandra
    Krzakowski, Maciej
    ONCOLOGY IN CLINICAL PRACTICE, 2019, 15 (03): : 150 - 157
  • [38] Clinical Implications of Additional Mutations Detected by Next-Generation Sequencing in EGFR-Mutant Lung Adenocarcinoma
    Kadauke, S.
    Hiemenz, M. C.
    Deshpande, C.
    Litzky, L. A.
    Roth, D. B.
    Ahmed, S.
    Aggarwal, C.
    Morrissette, J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2014, 16 (06): : 759 - 759
  • [39] Effect of Antibiotic Exposure on the Efficacy of EGFR TKIs in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer (NSCLC)
    Pengnoraphat, B.
    Saichaemchan, S.
    Thambamroong, T.
    Phavirunsiri, J.
    Peechatanan, K.
    Prasongsook, N.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S623 - S623
  • [40] EGFR mutations as a prognostic and predictive marker in non-small-cell lung cancer
    Fang, Shu
    Wang, Zhehai
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 1595 - 1611
12345